CBP-93872

CAS No. 67427-51-4

CBP-93872( CBP93872 | CBP 93872 )

Catalog No. M15571 CAS No. 67427-51-4

A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CBP-93872
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint.
  • Description
    A potent G2 checkpoint inhibitor that specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint; directly suppresses the growth of p53-mutated cancer cell lines with wild-type CDKN2A by eliciting G(1) arrest, but not CDKN2A-deleted and/or wild-type p53 lines; decreases phospho-cdc2 Y15 by inhibiting phosphorylation of Chk1; specifically inhibits DSB-mediated and Nbs1-dependent activation of ATR.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CBP93872 | CBP 93872
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ATM/ATR
  • Recptor
    ATM/ATR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    67427-51-4
  • Formula Weight
    259.14
  • Molecular Formula
    C10H15BrN2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(CNC1=CC=C(C)C=C1Br)CN
  • Chemical Name
    1-amino-3-((2-bromo-4-methylphenyl)amino)propan-2-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Harada N, et al. Anticancer Drugs. 2011 Nov;22(10):986-94. 2. Hirokawa T, et al. Cancer Res. 2014 Jul 15;74(14):3880-9. 3. Iwata T, et al. PLoS One. 2017 May 30;12(5):e0178221.
molnova catalog
related products
  • KU-55933

    KU-55933 is a potent, specific, ATP-competitive inhibitor of ATM with Ki/IC50 of 2.2/13 nM.

  • KU 59403

    KU 59403 is a selective and potent ATM inhibitor with antitumor and anticancer activity, inhibits ATM, DNA-PK and PI3K, and is often used in combination therapy with PARP or ATR inhibitors to slow the progression of cancer.

  • VE822

    VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.